GENAP Summit 2026

The GENAP Summit 2026 returns as a premier platform for advancing pharmaceutical manufacturing, aseptic processing, and Gene & Cell Therapy (GCT) innovations. As the industry accelerates toward automation, regulatory transformation, and breakthrough therapies, GENAP 2026 will provide unparalleled insights, case studies, and forward-thinking discussions.

This year’s unified program will explore the intersection of aseptic processing and GCT, covering key areas such as bioprocessing, viral vector manufacturing, regulatory compliance, and next-generation automation. Key topics include:

- Aseptic Processing & Advanced Manufacturing
Innovations in contamination control, cleanroom technology, and gloveless isolators
Annex 1 updates and their impact on aseptic production strategies
Automated fill-finish solutions and next-gen sterile manufacturing
- Gene & Cell Therapy: CMC, Viral Vectors & Bioprocessing
Optimizing CMC analytics for robust and scalable GCT production
Overcoming challenges in viral vector manufacturing and process intensification
Advanced bioprocessing strategies to improve yield, scalability, and regulatory compliance
- Pharma 4.0 & Robotics in Manufacturing
The role of AI, digital twins, and robotics in aseptic processing and ATMP production
Automation-driven GMP compliance and data-driven decision-making
The future of modular, flexible, and AI-powered biopharma facilities
- Regulatory & GMP Compliance in Aseptic & ATMPs
Annex 1 compliance strategies for sterile and ATMP manufacturing
Environmental monitoring, process validation, and risk management
Navigating the complex regulatory landscape for gene and cell therapies

Join us in Vienna for two days of strategic discussions, hands-on case studies, and high-impact networking. Engage with global experts, biotech pioneers, and pharma innovators as we shape the future of aseptic processing and advanced therapy manufacturing.